These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cai RD; Zhang CC; Xie LL; Wang PC; Huang CX; Chen JL; Lv HT Cancer Manag Res; 2020; 12():12011-12020. PubMed ID: 33262651 [TBL] [Abstract][Full Text] [Related]
3. SNHG1 promotes malignant biological behaviors of glioma cells via microRNA-154-5p/miR-376b-3p- FOXP2- KDM5B participating positive feedback loop. Li H; Xue Y; Ma J; Shao L; Wang D; Zheng J; Liu X; Yang C; He Q; Ruan X; Li Z; Liu Y J Exp Clin Cancer Res; 2019 Feb; 38(1):59. PubMed ID: 30728054 [TBL] [Abstract][Full Text] [Related]
4. DICER1-AS1 Promotes the Malignant Behaviors of Colorectal Cancer Cells by Regulating miR-296-5p/STAT3 Axis [Retraction]. Cancer Manag Res; 2023; 15():771-772. PubMed ID: 37525668 [TBL] [Abstract][Full Text] [Related]
5. microRNA-877 Inhibits Malignant Progression of Colorectal Cancer by Directly Targeting MTDH and Regulating the PTEN/Akt Pathway [Retraction]. Cancer Manag Res; 2021; 13():7489-7490. PubMed ID: 34611442 [TBL] [Abstract][Full Text] [Related]
6. LINC-PINT Inhibited Malignant Progression of Bladder Cancer by Targeting miR-155-5p [Retraction]. Cancer Manag Res; 2023; 15():1267-1268. PubMed ID: 38027244 [TBL] [Abstract][Full Text] [Related]
7. FtMt promotes glioma tumorigenesis and angiogenesis via lncRNA SNHG1/miR-9-5p axis. Mi S; Du J; Liu J; Hou K; Ji H; Ma S; Ba Y; Chen L; Xie R; Hu S Cell Signal; 2020 Nov; 75():109749. PubMed ID: 32858123 [TBL] [Abstract][Full Text] [Related]
8. LINC00908 Promotes Diffuse Large B-Cell Lymphoma Development by Down-Regulating miR-671-5p [Retraction]. Cancer Manag Res; 2021; 13():9347-9348. PubMed ID: 34992458 [TBL] [Abstract][Full Text] [Related]
9. Loss of miR-204-5p Promotes Tumor Proliferation, Migration, and Invasion Through Targeting YWHAZ/PI3K/AKT Pathway in Esophageal Squamous Cell Carcinoma [Retraction]. Onco Targets Ther; 2023; 16():801-802. PubMed ID: 37794861 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA-139-5p modulates the growth and metastasis of malignant melanoma cells via the PI3K/AKT signaling pathway by binding to IGF1R. Yang C; Xia Z; Zhu L; Li Y; Zheng Z; Liang J; Wu L Cell Cycle; 2019 Dec; 18(24):3513-3524. PubMed ID: 31724454 [TBL] [Abstract][Full Text] [Related]
12. Long Non-Coding RNA LINC01783 Promotes the Progression of Cervical Cancer by Sponging miR-199b-5p to Mediate GBP1 Expression [Retraction]. Cancer Manag Res; 2022; 14():967-968. PubMed ID: 35283646 [TBL] [Abstract][Full Text] [Related]
13. miR-140-5p Alleviates The Aggressive Progression Of Wilms' Tumor Through Directly Targeting Cancer Manag Res; 2019; 11():8605. PubMed ID: 31576166 [TBL] [Abstract][Full Text] [Related]
15. LncRNA SNHG1 contributes to the cisplatin resistance and progression of NSCLC via miR-330-5p/DCLK1 axis. Ge P; Cao L; Zheng M; Yao Y; Wang W; Chen X Exp Mol Pathol; 2021 Jun; 120():104633. PubMed ID: 33753110 [TBL] [Abstract][Full Text] [Related]
16. Knockdown of circHIPK3 Facilitates Temozolomide Sensitivity in Glioma by Regulating Cellular Behaviors Through miR-524-5p/KIF2A-Mediated PI3K/AKT Pathway. Yin H; Cui X Cancer Biother Radiopharm; 2021 Sep; 36(7):556-567. PubMed ID: 32833501 [No Abstract] [Full Text] [Related]
17. miR-188-5p Promotes Tumor Growth by Targeting CD2AP Through PI3K/AKT/mTOR Signaling in Children with Acute Promyelocytic Leukemia [Retraction]. Onco Targets Ther; 2023; 16():1025-1026. PubMed ID: 38090111 [TBL] [Abstract][Full Text] [Related]
18. Long Non-Coding RNA AGAP2-AS1/miR-628-5p/PTN Axis Modulates Proliferation, Migration, Invasion, and Apoptosis of Glioma Cells [Retraction]. Cancer Manag Res; 2020; 12():9711. PubMed ID: 33116829 [TBL] [Abstract][Full Text] [Related]
19. Columbamine-Mediated PTEN/AKT Signal Pathway Regulates the Progression of Glioma [Retraction]. Cancer Manag Res; 2021; 13():5761. PubMed ID: 34321923 [TBL] [Abstract][Full Text] [Related]
20. LncRNA MALAT1 Promotes Survival of Epithelial Ovarian Cancer Cells by Downregulating miR-145-5p [Retraction]. Cancer Manag Res; 2021; 13():7251-7252. PubMed ID: 34584451 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]